Skip to content

Primary Spontaneous Pneumothorax and Renal Cell Carcinoma

Primary Spontaneous Pneumothorax and Renal Cell Carcinoma - PSP-RCC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON54609
Enrollment
350
Registered
2019-09-26
Start date
2020-09-07
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

longaandoening: pneumothorax lung collaps by air in the pleural cavity pneumothorax

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
16 Years to 64 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: -Able to give written informed consent prior to participation in the study. Subjects must be able to read, comprehend and write at a level sufficient to complete study related materials. -Subjects must have a diagnosis of spontaneous pneumothorax (this might be a 2nd PSP if not proven to be related to a known disease or first contralateral pneumothorax) -Age: at least 16 years of age at visit 1 -Gender: male or female

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: -Age

Design outcomes

Primary

MeasureTime frame
The prevalence of pulmonary parenchyma abnormalities which can be found by performing low-dose CT scan of the chest and which are probably related to Birt-Hogg-Dube syndrome in patients presenting with primary spontaneous pneumothorax.

Secondary

MeasureTime frame
The prevalence of Birt-Hogg-Dube syndrome based on finding the folliculin gene mutation in a cohort of patients with primary spontaneous pneumothorax. Other abnormalities in the pulmonary parenchyma found by performing low-dose CT of the chest and probably related to the primary spontaneous pneumothorax.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)